...
首页> 外文期刊>Lipids in Health Disease >Deletion of the Mir-106b~?25 MicroRNA cluster attenuates atherosclerosis in Apolipoprotein E knockout mice
【24h】

Deletion of the Mir-106b~?25 MicroRNA cluster attenuates atherosclerosis in Apolipoprotein E knockout mice

机译:Mir-106b〜?25 MicroRNA簇的缺失减弱了载脂蛋白E基因敲除小鼠的动脉粥样硬化

获取原文

摘要

Abstract BackgroundMicroRNAs are short non-coding RNAs that regulate gene expression. The aim of this study was to gain an understanding of the possible role of the miR-106b~?25 microRNA cluster in regulating atherosclerosis in mice.MethodsMiR-106b~?25 knockout mice were outcrossed into Apolipoprotein E (ApoE) knockout background to generate double knockout mice. At 36?weeks of age, lesion size was evaluated in the aortic sinus by oil-red-O staining.ResultsLesion size was 2-fold smaller in double KO mice in comparison to ApoE KO mice . In addition, collagen staining showed a trend towards a stable plaque phenotype in the double KO mice. Lipid profiling of plasma samples of double KO and ApoE KO mice using FPLC revealed over 2-fold decrease in Very low density lipoprotein (VLDL) cholesterol content and a 50% decrease in low density lipoprotein (LDL) cholesterol content in double KO mice. By using target prediction software, we have identified several possible targets for the miR-106b~?25 cluster including the VLDL and LDL receptors. We found that upon feeding miR-106b~?25 KO mice with high fat diet, the expression of LDL and VLDL receptors was higher than in the wild-type mice, suggesting the miR-106b~?25 cluster regulates atherosclerosis by influencing clearance of VLDL and LDL from the plasma.ConclusionsWe identified the miR-106b~?25 cluster as a novel regulator of atherosclerosis in ApoE KO mice, presumably by regulating plasma cholesterol levels.
机译:摘要背景MicroRNA是调节基因表达的短非编码RNA。这项研究的目的是要了解miR-106b〜?25 microRNA簇在调节小鼠动脉粥样硬化中的可能作用。方法将MiR-106b〜?25敲除小鼠杂交至载脂蛋白E(ApoE)敲除背景以产生双敲除小鼠。在36周龄时,通过油红O染色评估了主动脉窦的病变大小。结果与ApoE KO小鼠相比,双KO小鼠的病变大小小2倍。另外,胶原蛋白染色在双KO小鼠中显示出趋向稳定的噬菌斑表型的趋势。使用FPLC对双KO和ApoE KO小鼠的血浆样品进行脂质分析显示,双KO小鼠的极低密度脂蛋白(VLDL)胆固醇含量降低了2倍以上,而低密度脂蛋白(LDL)胆固醇含量降低了50%。通过使用目标预测软件,我们已经确定了miR-106b〜?25簇的几个可能的目标,包括VLDL和LDL受体。我们发现以高脂饮食喂养miR-106b〜?25 KO小鼠后,LDL和VLDL受体的表达高于野生型小鼠,这表明miR-106b〜?25团簇通过影响脂蛋白的清除来调节动脉粥样硬化。结论我们确定了miR-106b〜25簇是ApoE KO小鼠动脉粥样硬化的新型调节剂,大概是通过调节血浆胆固醇水平来实现的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号